165 related articles for article (PubMed ID: 33839315)
1. A pilot study indicating the dysregulation of the complement and coagulation cascades in treated schizophrenia and bipolar disorder patients.
Santa Cruz EC; Zandonadi FDS; Fontes W; Sussulini A
Biochim Biophys Acta Proteins Proteom; 2021 Aug; 1869(8):140657. PubMed ID: 33839315
[TBL] [Abstract][Full Text] [Related]
2. Association between trace elements in serum from bipolar disorder and schizophrenia patients considering treatment effects.
Santa Cruz EC; Madrid KC; Arruda MAZ; Sussulini A
J Trace Elem Med Biol; 2020 May; 59():126467. PubMed ID: 31954929
[TBL] [Abstract][Full Text] [Related]
3. Metallomics-based platforms for comparing the human blood serum profiles between bipolar disorder and schizophrenia patients.
de Souza Pessôa G; de Jesus JR; Balbuena TS; Arruda MAZ
Rapid Commun Mass Spectrom; 2020 Sep; 34 Suppl 3():e8698. PubMed ID: 31837042
[TBL] [Abstract][Full Text] [Related]
4. Identification of plasma biomarkers for distinguishing bipolar depression from major depressive disorder by iTRAQ-coupled LC-MS/MS and bioinformatics analysis.
Ren J; Zhao G; Sun X; Liu H; Jiang P; Chen J; Wu Z; Peng D; Fang Y; Zhang C
Psychoneuroendocrinology; 2017 Dec; 86():17-24. PubMed ID: 28910601
[TBL] [Abstract][Full Text] [Related]
5. Comparative serum proteomic analysis of a selected protein panel in individuals with schizophrenia and bipolar disorder and the impact of genetic risk burden on serum proteomic profiles.
Oraki Kohshour M; Kannaiyan NR; Falk AJ; Papiol S; Heilbronner U; Budde M; Kalman JL; Schulte EC; Rietschel M; Witt S; Forstner AJ; Heilmann-Heimbach S; Nöthen MM; Spitzer C; Malchow B; Müller T; Wiltfang J; Falkai P; Schmitt A; Rossner MJ; Nilsson P; Schulze TG
Transl Psychiatry; 2022 Nov; 12(1):471. PubMed ID: 36351892
[TBL] [Abstract][Full Text] [Related]
6. Simplifying the human serum proteome for discriminating patients with bipolar disorder of other psychiatry conditions.
de Jesus JR; Galazzi RM; de Lima TB; Banzato CEM; de Almeida Lima E Silva LF; de Rosalmeida Dantas C; Gozzo FC; Arruda MAZ
Clin Biochem; 2017 Dec; 50(18):1118-1125. PubMed ID: 28662995
[TBL] [Abstract][Full Text] [Related]
7. Common and distinct structural features of schizophrenia and bipolar disorder: The European Network on Psychosis, Affective disorders and Cognitive Trajectory (ENPACT) study.
Maggioni E; Crespo-Facorro B; Nenadic I; Benedetti F; Gaser C; Sauer H; Roiz-Santiañez R; Poletti S; Marinelli V; Bellani M; Perlini C; Ruggeri M; Altamura AC; Diwadkar VA; Brambilla P;
PLoS One; 2017; 12(11):e0188000. PubMed ID: 29136642
[TBL] [Abstract][Full Text] [Related]
8. DNA hypermethylation of serotonin transporter gene promoter in drug naïve patients with schizophrenia.
Abdolmaleky HM; Nohesara S; Ghadirivasfi M; Lambert AW; Ahmadkhaniha H; Ozturk S; Wong CK; Shafa R; Mostafavi A; Thiagalingam S
Schizophr Res; 2014 Feb; 152(2-3):373-80. PubMed ID: 24411530
[TBL] [Abstract][Full Text] [Related]
9. Primary cilia formation is diminished in schizophrenia and bipolar disorder: A possible marker for these psychiatric diseases.
Muñoz-Estrada J; Lora-Castellanos A; Meza I; Alarcón Elizalde S; Benítez-King G
Schizophr Res; 2018 May; 195():412-420. PubMed ID: 28927861
[TBL] [Abstract][Full Text] [Related]
10. Regulation of inflammatory pathways in schizophrenia: A comparative study with bipolar disorder and healthy controls.
García-Álvarez L; Caso JR; García-Portilla MP; de la Fuente-Tomás L; González-Blanco L; Sáiz Martínez P; Leza JC; Bobes J
Eur Psychiatry; 2018 Jan; 47():50-59. PubMed ID: 29102659
[TBL] [Abstract][Full Text] [Related]
11. Systematic Review and Meta-Analysis of Mass Spectrometry Proteomics Applied to Human Peripheral Fluids to Assess Potential Biomarkers of Schizophrenia.
Rodrigues JE; Martinho A; Santa C; Madeira N; Coroa M; Santos V; Martins MJ; Pato CN; Macedo A; Manadas B
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563307
[TBL] [Abstract][Full Text] [Related]
12. Systematic Review and Meta-Analysis on MS-Based Proteomics Applied to Human Peripheral Fluids to Assess Potential Biomarkers of Bipolar Disorder.
Rodrigues JE; Martinho A; Santos V; Santa C; Madeira N; Martins MJ; Pato CN; Macedo A; Manadas B
Int J Mol Sci; 2022 May; 23(10):. PubMed ID: 35628270
[TBL] [Abstract][Full Text] [Related]
13. Reduced number of peripheral natural killer cells in schizophrenia but not in bipolar disorder.
Karpiński P; Frydecka D; Sąsiadek MM; Misiak B
Brain Behav Immun; 2016 May; 54():194-200. PubMed ID: 26872421
[TBL] [Abstract][Full Text] [Related]
14. Peripheral biomarkers allow differential diagnosis between schizophrenia and bipolar disorder.
Tasic L; Larcerda ALT; Pontes JGM; da Costa TBBC; Nani JV; Martins LG; Santos LA; Nunes MFQ; Adelino MPM; Pedrini M; Cordeiro Q; Bachion de Santana F; Poppi RJ; Brietzke E; Hayashi MAF
J Psychiatr Res; 2019 Dec; 119():67-75. PubMed ID: 31568986
[TBL] [Abstract][Full Text] [Related]
15. Label-free quantitative proteomic analysis reveals dysfunction of complement pathway in peripheral blood of schizophrenia patients: evidence for the immune hypothesis of schizophrenia.
Li Y; Zhou K; Zhang Z; Sun L; Yang J; Zhang M; Ji B; Tang K; Wei Z; He G; Gao L; Yang L; Wang P; Yang P; Feng G; He L; Wan C
Mol Biosyst; 2012 Oct; 8(10):2664-71. PubMed ID: 22797129
[TBL] [Abstract][Full Text] [Related]
16. Altered systemic cortisol metabolism in bipolar disorder and schizophrenia spectrum disorders.
Steen NE; Methlie P; Lorentzen S; Dieset I; Aas M; Nerhus M; Haram M; Agartz I; Melle I; Berg JP; Andreassen OA
J Psychiatr Res; 2014 May; 52():57-62. PubMed ID: 24534618
[TBL] [Abstract][Full Text] [Related]
17. Postmortem transcriptional profiling reveals widespread increase in inflammation in schizophrenia: a comparison of prefrontal cortex, striatum, and hippocampus among matched tetrads of controls with subjects diagnosed with schizophrenia, bipolar or major depressive disorder.
Lanz TA; Reinhart V; Sheehan MJ; Rizzo SJS; Bove SE; James LC; Volfson D; Lewis DA; Kleiman RJ
Transl Psychiatry; 2019 May; 9(1):151. PubMed ID: 31123247
[TBL] [Abstract][Full Text] [Related]
18. Retinal vascular fractal dimension in bipolar disorder and schizophrenia.
Appaji A; Nagendra B; Chako DM; Padmanabha A; Hiremath CV; Jacob A; Varambally S; Kesavan M; Venkatasubramanian G; Rao SV; Webers CAB; Berendschot TTJM; Rao NP
J Affect Disord; 2019 Dec; 259():98-103. PubMed ID: 31445346
[TBL] [Abstract][Full Text] [Related]
19. Antibody profiling of bipolar disorder using Escherichia coli proteome microarrays.
Chen PC; Syu GD; Chung KH; Ho YH; Chung FH; Chen PH; Lin JM; Chen YW; Tsai SY; Chen CS
Mol Cell Proteomics; 2015 Mar; 14(3):510-8. PubMed ID: 25540388
[TBL] [Abstract][Full Text] [Related]
20. Perceived stress and hair cortisol: Differences in bipolar disorder and schizophrenia.
Streit F; Memic A; Hasandedić L; Rietschel L; Frank J; Lang M; Witt SH; Forstner AJ; Degenhardt F; Wüst S; Nöthen MM; Kirschbaum C; Strohmaier J; Oruc L; Rietschel M
Psychoneuroendocrinology; 2016 Jul; 69():26-34. PubMed ID: 27017430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
